Laboratorio Farmaceutico CT Srl has a long-time experience in the chemical and pharmaceutical research, which is especially devoted to the study of new and innovative drugs for alcohol addiction. A drug for the overall treatment of upsets related to alcohol consumption is already in commerce in Italy and Austria and about 20,000 patients/year employ this therapy. A new pharmaceutical formula of this product, recently developed and studied, is ready to be internationally registered.
Another product in pipeline has been recently authorized by FDA for a clinical study in the USA and at present it is under clinical phase 2.
Laboratorio Farmaceutico CT Srl is furthermore able to provide to its customers support work for:
• Analytical development and validation
• Process validation
• ICH stability studies
• eCTD and CTD dossier compilation
• Regulatory support to keep product and marketing authorization updated with the existing national and international regulations.